• Cancer Discovery

    Cancer Discovery is the one-stop source for information in cancer science and medicine. The journal includes the following sections: News, Research Watch, Views, Mini Reviews, Reviews, Research Briefs, and Research Articles.

  • Cancer Research

    Cancer Research publishes original studies, reviews, and opinion pieces offering significance and broad impact to a diverse audience spanning basic, preclinical, clinical, prevention, and epidemiologic research. Cancer Research seeks manuscripts that offer pathobiological and translational impact to inform the personal, clinical, and societal problems posed by cancer. The main scope of the Journal is captured in its primary subsections, which focus on integrated systems and technology, microenvironment and immunology, molecular and cellular pathobiology, prevention and epidemiology, therapeutics and targets, and tumor and stem cell biology.

  • Nature Reviews Clinical Oncology

    Nature Reviews Clinical Oncology's clinical content is written by internationally renowned clinical academics and researchers and targeted towards readers in the medical sciences, from postgraduate level upwards. While intended to be read by practicing doctors, researchers and academics within a specialty, we aim to make all our articles accessible to readers working in any medical discipline.

  • Journal of the National Cancer Institute

    The Journal of the National Cancer Institute (JNCI) publishes peer-reviewed original research from around the world and is internationally acclaimed as the source for the most up-to-date news and information from the rapidly changing fields of cancer research and treatment. For the past several years, the JNCI has been ranked as one of the most-cited original-research cancer journals by the Institute of Scientific Information in its annual Journal Citation Reports.

  • Cancer Cell

    Cancer Cell provides a high-profile forum to promote major advances in cancer research and oncology. The primary criterion for considering papers is whether the studies provide major advances into answering the important questions relevant to naturally occurring cancers.

  • Lancet Oncology

    The Lancet Oncology publishes interesting and informative reviews on any topic connected with oncology, and considers any original research contribution that advocates change in, or illuminates, oncological clinical practice. 

  • Nature Reviews Cancer

    Nature Reviews Cancer will be a gateway from which cancer researchers — from those investigating the molecular basis of cancer to those involved in translational research — access the information that they need to further the ability to diagnose, treat and ultimately prevent cancer.

  • Medical Oncology

    Medical Oncology (MO) communicates the results of clinical and experimental research in oncology and hematology, particularly experimental therapeutics within the fields of immunotherapy and chemotherapy. It also provides state-of-the-art reviews on clinical and experimental therapies. Topics covered include immunobiology, pathogenesis, and treatment of malignant tumors.  

  • Advances in Hematology

    Advances in Hematology is a peer-reviewed, open access journal that publishes original research articles, review articles, and clinical studies in all areas of hematology.

  • Clinical Lymphoma, Myeloma and Leukemia

    Clinical Lymphoma, Myeloma & Leukemia is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of lymphoma, myeloma and leukemia. Clinical Lymphoma, Myeloma & Leukemia is devoted to articles on detection, diagnosis, prevention, and treatment of lymphoma, myeloma, leukemia and related disorders including macroglobulinemia, amyloidosis, and plasma-cell dyscrasias. The main emphasis is on recent scientific developments in all areas related to lymphoma, myeloma and leukemia. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.